For example, RKIP has been reported to inhibit local breast cancer invasion by antagonizing the transcriptional activation of MMP-13, mediated by the ERK2 signaling pathway and independently of the ERK2 downstream target activator protein 1 (AP-1) [102]. This evidence concerns the gene PEBP1 and breast carcinoma.